Search results for "topos"

showing 10 items of 153 documents

Ornamentation of dermal bones of Metoposaurus krasiejowensis and its ecological implications

2018

Background Amphibians are animals strongly dependent on environmental conditions, like temperature, water accessibility, and the trophic state of the reservoirs. Thus, they can be used in modern palaeoenvironmental analysis, reflecting ecological condition of the biotope. Methods To analyse the observed diversity in the temnospondyl Metoposaurus krasiejowensis from Late Triassic deposits in Krasiejów (Opole Voivodeship, Poland), the characteristics of the ornamentation (such as grooves, ridges, tubercules) of 25 clavicles and 13 skulls were observed on macro- and microscales, including the use of a scanning electron microscope for high magnification. The different ornamentation patterns fo…

0106 biological sciencesAmphibianBiotope010506 paleontologyPopulationlcsh:MedicineSculptureMetoposaurus010603 evolutionary biology01 natural sciencesGeneral Biochemistry Genetics and Molecular BiologyTemnospondylibiology.animaleducationNeoteny0105 earth and related environmental sciencesTrophic leveleducation.field_of_studybiologyEcologyGeneral Neurosciencelcsh:RSkullTemnospondyliPalaeoecologyFossilGeneral MedicineAmphibianbiology.organism_classificationClavicleSexual dimorphismGeneral Agricultural and Biological SciencesPeerJ
researchProduct

Merging cranial histology and 3D-computational biomechanics : A review of the feeding ecology of a Late Triassic temnospondyl amphibian

2021

Finite Element Analysis (FEA) is a useful method for understanding form and function. However, modelling of fossil taxa invariably involves assumptions as a result of preservation-induced loss of information in the fossil record. To test the validity of predictions from FEA, given such assumptions, these results could be compared to independent lines of evidence for cranial mechanics. In the present study a new concept of using bone microstructure to predict stress distribution in the skull during feeding is put forward and a correlation between bone microstructure and results of computational biomechanics (FEA) is carried out. The bony framework is a product of biological optimisation; bon…

0106 biological sciencesAmphibianskull010506 paleontologyHistologyForaginglcsh:MedicineBioengineeringMetoposaurus010603 evolutionary biology01 natural sciencesGeneral Biochemistry Genetics and Molecular BiologyPaleontologyTemnospondylibiology.animalDermal boneMetoposaurusmedicinefeeding strategyFEA0105 earth and related environmental sciencesDermal bonebiologyGeneral Neurosciencelcsh:RSkullMode (statistics)PaleontologyTemnospondyliGeneral Medicinedermal bonebiology.organism_classificationBone histologySkullbone histologymedicine.anatomical_structureBitingGeneral Agricultural and Biological SciencesFeeding strategyGeology
researchProduct

Spatial variability of macrozoobenthic community and trophic structure of a subtropical lagoon on southeastern Brazil's Atlantic coast

2013

The objective of this study was to investigate the macrobenthic community of two compartments of the Maricá-Guarapina lagoon system, along the coast of Rio de Janeiro, Brazil, in relation to its abiotic sediment factors. An additional discrimination between sites was made, wherever the macrophyte Typha domingensis was found. This vegetation supposedly represents a potentially important food source for consumers. Furthermore, the trophic pathways were analyzed functionally by means of stable isotope analysis to assess the role of organic matter sources for consumers in the study area. In conclusion, the results showed differences between abiotic features in the compartments of the lagoon sys…

0106 biological sciencesSistema Lagunar Costeiro SubtropicalMacroozoobenthos010604 marine biology & hydrobiologyBrasilStable IsotopesSubtropical Coastal LagoonForestryIsótopos Estáveis15. Life on landOceanography010603 evolutionary biology01 natural sciencesBrazil Macrozoobenthos Stable Isotopes Subtropical Coastal Lagoon.lcsh:OceanographyGeographyMacrozoobenthoslcsh:GC1-1581Brazil
researchProduct

Class I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells

2016

The transcription factors NF-κB and p53 as well as their crosstalk determine the fate of tumor cells upon therapeutic interventions. Replicative stress and cytokines promote signaling cascades that lead to the co-regulation of p53 and NF-κB. Consequently, nuclear p53/NF-κB signaling complexes activate NF-κB-dependent survival genes. The 18 histone deacetylases (HDACs) are epigenetic modulators that fall into four classes (I-IV). Inhibitors of histone deacetylases (HDACi) become increasingly appreciated as anti-cancer agents. Based on their effects on p53 and NF-κB, we addressed whether clinically relevant HDACi affect the NF-κB/p53 crosstalk. The chemotherapeutics hydroxyurea, etoposide, an…

0301 basic medicineDNA damageApoptosisModels BiologicalHistone Deacetylases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCell Line TumorNeoplasmsHumansHydroxyureaEpigeneticsTranscription factorCellular SenescenceEtoposidebiologyNF-kappa BNF-κBCell Cycle CheckpointsDNA NeoplasmCell BiologyHDAC6Gene Expression Regulation NeoplasticHistone Deacetylase InhibitorsCrosstalk (biology)030104 developmental biologyHistonechemistry030220 oncology & carcinogenesisMutationCancer cellbiology.proteinCancer researchTumor Suppressor Protein p53VidarabineDNA DamageSignal TransductionCellular Signalling
researchProduct

Structure-Activity Relationships of Cytotoxic Lactones as Inhibitors and Mechanisms of Action.

2020

Background: Some lactones prevent protein Myb-dependent gene expression. Objective: The object is to calculate inhibitors of Myb-brought genetic manifestation. Methods: Linear quantitative structure–potency relations result expanded, among sesquiterpene lactones of a variety of macrocycles (pseudoguaianolides, guaianolides, eudesmanolides and germacranolides), to establish which part of the molecule constitutes their pharmacophore, and predict their inhibitory potency on Myb-reliant genetic manifestation, which may result helpful as leads for antileukaemic therapies with a new mechanism of action. Results: Several count indices are connected with structure–activity. The α-methylene-γ-lacto…

0301 basic medicineGermacranolidePaclitaxelStereochemistrySesquiterpeneRing (chemistry)Ligands030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compoundLactonesStructure-Activity Relationship0302 clinical medicineTubulinNeoplasmsDrug DiscoverymedicinePotencyMoleculeHumansEtoposidechemistry.chemical_classification030102 biochemistry & molecular biologyAntineoplastic Agents PhytogenicTubulin ModulatorsMolecular Docking SimulationMechanism of actionchemistryStructural Homology ProteinDrug DesignPharmacophoremedicine.symptomTopotecanSesquiterpenesLactoneCurrent drug discovery technologies
researchProduct

Pentadactyl manus of the Metoposaurus krasiejowensis from the Late Triassic of Poland, the first record of pentadactyly among Temnospondyli

2020

Abstract Temnospondyli are commonly believed to have possessed four digits in the manus and five in the pes. However, actual finds of articulated autopodia are extremely rare. Therefore, an articulated, slightly incomplete forelimb skeleton with preserved manus of Metoposaurus krasiejowensis from the Late Triassic of Poland is important in providing new details about the structure and ossification sequence in the temnospondyl limb. The most important observation is the presence of five metacarpals in this specimen. This allows reconstructing the manus as pentadactyl. The number of phalanges and the distribution of distal articulation facets allow reconstruction of the digit formula as (2?)‐…

0301 basic medicineHistologyManusMetoposaurusAmphibians03 medical and health sciences0302 clinical medicinemanusTemnospondyliMetoposaurusForelimbmedicineAnimalsdigitsMolecular BiologyEcology Evolution Behavior and SystematicsPhylogenybiologyOssificationFossilsTemnospondyliCell BiologyAnatomyPhalanxbiology.organism_classificationOriginal PapersBiological EvolutionNumerical digitossification030104 developmental biologyGeographyOriginal ArticlePolandAnatomymedicine.symptom030217 neurology & neurosurgeryDevelopmental BiologyJournal of Anatomy
researchProduct

Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.

2017

Objective Malignant ovarian germ cell tumors (MOGCT) carry an excellent prognosis, and the treatment aims to achieve results with the least possible treatment-related morbidity. The aim of this study was to assess the outcomes of pediatric patients with MOGCT. Methods Patients were treated according to their stage: surgery and surveillance for stage I; a modified bleomycin–etoposide–cisplatin (BEP) regimen for stages II (three cycles), III, and IV (three cycles) with surgery on residual disease. Results Seventy-seven patients were enrolled (median age 11.8 years), 26 with dysgerminoma (Dysg), 13 with immature teratoma and elevated serum alpha-fetoprotein levels (IT + AFP), and 38 with nondy…

0301 basic medicineMalechildhood; germ cell tumors; ovarianGastroenterology0302 clinical medicineAntineoplastic Combined Chemotherapy ProtocolsMedicineProspective StudiesStage (cooking)germ cell tumorsProspective cohort studyChildEtoposideOvarian NeoplasmsHematologychildhood germ cell tumors ovarianNeoplasms Germ Cell and EmbryonalPrognosisCombined Modality TherapySurvival RateOncology030220 oncology & carcinogenesisChild PreschoolFemalemedicine.medical_specialtyAdolescentOvariectomy03 medical and health sciencesBleomycinInternal medicineDysgerminomaovarianHumansSurvival ratechildhoodNeoplasm Stagingbusiness.industrySettore MED/20 - Chirurgia Pediatrica E InfantileInfantmedicine.diseaseSurgeryRegimen030104 developmental biologyPediatrics Perinatology and Child HealthSettore MED/20Immature teratomaGerm cell tumorsCisplatinbusinessProgressive diseaseFollow-Up StudiesPediatric bloodcancer
researchProduct

The effectiveness of combination chemotherapy with cisplatinum and etoposide in the treatment of advanced non-small cell lung cancer.

1989

Twenty-one patients with histologically proven advanced or disseminated non-small cell lung cancer were treated with cisplatinum 80 mg/m2 i.v. day 1 and etoposide (VP16) 80 mg/m2 i.v. day 1- greater than 3.15 patients were evaluable for response. One patient (6.6%) achieved a complete response, 4 (26.7%) a partial response and 6 (40.0%) a stabilization of disease. Four patients (26.7%) progressed. An improvement in performance status was obtained in more than 50% of cases. Responders had a mean survival of 345 + days, while non-responders 191.7 days. The treatment was generally well tolerated. In our opinion this combination regimen offers good palliation for patients affected by advanced a…

0301 basic medicineOncologyMalemedicine.medical_specialtyLung Neoplasms030106 microbiologyDisease03 medical and health sciences0302 clinical medicineInternal medicineCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansPharmacology (medical)Lung cancerEtoposideAgedEtoposidePharmacologyCisplatinPerformance statusbusiness.industryCombination chemotherapyMiddle Agedmedicine.diseaseRegimenInfectious DiseasesOncology030220 oncology & carcinogenesisFemaleNon small cellCisplatinbusinessmedicine.drugJournal of chemotherapy (Florence, Italy)
researchProduct

Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients

2017

Background: Results from the BEVA2007 trial, suggest that the metronomic chemotherapy regimen with dose-fractioned cisplatin and oral etoposide (mPE) +/− bevacizumab, a monoclonal antibody to the vascular endothelial growth factor (VEGF), shows anti-angiogenic and immunological effects and is a safe and active treatment for metastatic non-small cell lung cancer (mNSCLC) patients. We carried out a retrospective analysis aimed to evaluate the antitumor effects of this treatment in a subset of patients with squamous histology. Methods: Retrospective analysis was carried out in a subset of 31 patients with squamous histology enrolled in the study between September 2007 and September 2015. All o…

0301 basic medicineOncologyPulmonary and Respiratory Medicinemedicine.medical_specialtyPathologyBevacizumabmedicine.medical_treatmentSquamous-NSCLC (sqNSCLC)03 medical and health sciences0302 clinical medicineInternal medicinemedicineProgression-free survivalRadical surgeryEtoposideEtoposideChemotherapybusiness.industryMetronomic chemotherapyCancermedicine.diseaseMetronomic ChemotherapyBevacizumabRegimen030104 developmental biology030220 oncology & carcinogenesisOriginal ArticleCisplatinbusinessBevacizumab; Cisplatin; Etoposide; Metronomic chemotherapy; Squamous-NSCLC (sqNSCLC); Pulmonary and Respiratory Medicinemedicine.drug
researchProduct

Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned ci…

2017

// Pierpaolo Pastina 1 , Valerio Nardone 1 , Cirino Botta 2 , Stefania Croci 1 , Paolo Tini 1 , Giuseppe Battaglia 1 , Veronica Ricci 3 , Maria Grazia Cusi 4 , Claudia Gandolfo 4 , Gabriella Misso 5 , Silvia Zappavigna 5 , Michele Caraglia 5,6 , Antonio Giordano 6,7 , Donatella Aldinucci 8 , Pierfrancesco Tassone 2,6 , Pierosandro Tagliaferri 2 , Luigi Pirtoli 1 and Pierpaolo Correale 1,9 1 Radiotherapy Unit, Department of Medicine, Surgery, and Neuroscience, Siena University Hospital, Siena, Italy 2 Medical Oncology Unit, AUO “Mater Domini”, “Magna Graecia” University, Catanzaro, Italy 3 Radiology Unit,Department of Medicine, Surgery, and Neuroscience, Siena University Hospital, Siena, Ita…

0301 basic medicineOncologymedicine.medical_specialtyRetrospective analysiBevacizumabmedicine.medical_treatmentRetrospective analysisNSCLC03 medical and health sciences0302 clinical medicineInternal medicineMedicineLung cancerEtoposideCisplatinbusiness.industryMetronomic chemotherapyAbscopal effectmedicine.diseaseMetronomic ChemotherapyImmune-modulationSurgeryRadiation therapyRadiation therapyRegimen030104 developmental biologyOncology030220 oncology & carcinogenesisNSCLC; immune-modulation; metronomic chemotherapy; radiation therapy; retrospective analysisbusinessmedicine.drugResearch Paper
researchProduct